| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.77e-08 | 3 | 53 | 3 | GO:0005220 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 6.30e-06 | 14 | 53 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.40e-05 | 18 | 53 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 7.53e-05 | 31 | 53 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 9.11e-05 | 33 | 53 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | alcohol binding | 1.55e-04 | 102 | 53 | 4 | GO:0043178 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.52e-04 | 70 | 53 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.32e-03 | 308 | 53 | 5 | GO:0008017 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.48e-03 | 316 | 53 | 5 | GO:0035091 | |
| GeneOntologyBiologicalProcess | microtubule-based process | SLK ANK3 KIF26B TTC21A FES KLC4 GOLGA8A DNAH9 LYST KLC3 KIF11 CFAP46 DCTN3 | 1.96e-06 | 1058 | 53 | 13 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule-based movement | 3.47e-05 | 493 | 53 | 8 | GO:0007018 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 1.28e-06 | 9 | 53 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 2.50e-06 | 11 | 53 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | microtubule associated complex | 5.42e-05 | 161 | 53 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 7.33e-05 | 88 | 53 | 4 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.00e-04 | 114 | 53 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | kinesin complex | 2.61e-04 | 49 | 53 | 3 | GO:0005871 | |
| GeneOntologyCellularComponent | microtubule | 3.76e-04 | 533 | 53 | 7 | GO:0005874 | |
| HumanPheno | Bilateral facial palsy | 2.77e-05 | 3 | 16 | 2 | HP:0430025 | |
| Domain | InsP3_rcpt-bd | 2.04e-08 | 3 | 52 | 3 | IPR000493 | |
| Domain | RIH_assoc | 4.05e-07 | 6 | 52 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 4.05e-07 | 6 | 52 | 3 | IPR013662 | |
| Domain | RYDR_ITPR | 4.05e-07 | 6 | 52 | 3 | PF01365 | |
| Domain | RIH_dom | 4.05e-07 | 6 | 52 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.05e-07 | 6 | 52 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.05e-07 | 6 | 52 | 3 | IPR015925 | |
| Domain | Ins145_P3_rec | 4.05e-07 | 6 | 52 | 3 | PF08709 | |
| Domain | - | 4.05e-07 | 6 | 52 | 3 | 1.25.10.30 | |
| Domain | MIR | 2.41e-06 | 10 | 52 | 3 | PS50919 | |
| Domain | MIR | 2.41e-06 | 10 | 52 | 3 | PF02815 | |
| Domain | MIR | 2.41e-06 | 10 | 52 | 3 | SM00472 | |
| Domain | MIR_motif | 2.41e-06 | 10 | 52 | 3 | IPR016093 | |
| Domain | Kinesin_light | 4.55e-05 | 4 | 52 | 2 | IPR002151 | |
| Domain | Rabaptin_Rab5-bd_dom | 1.13e-04 | 6 | 52 | 2 | IPR015390 | |
| Domain | Rab5-bind | 1.13e-04 | 6 | 52 | 2 | PF09311 | |
| Domain | BIR | 2.11e-04 | 8 | 52 | 2 | SM00238 | |
| Domain | BIR_REPEAT_2 | 2.11e-04 | 8 | 52 | 2 | PS50143 | |
| Domain | - | 2.11e-04 | 8 | 52 | 2 | 1.10.1170.10 | |
| Domain | BIR_rpt | 2.11e-04 | 8 | 52 | 2 | IPR001370 | |
| Domain | BIR_REPEAT_1 | 2.11e-04 | 8 | 52 | 2 | PS01282 | |
| Domain | BIR | 2.11e-04 | 8 | 52 | 2 | PF00653 | |
| Domain | TPR | 1.14e-03 | 165 | 52 | 4 | PS50005 | |
| Domain | TPR_REGION | 1.14e-03 | 165 | 52 | 4 | PS50293 | |
| Domain | NACHT | 1.85e-03 | 23 | 52 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 1.85e-03 | 23 | 52 | 2 | IPR007111 | |
| Domain | TPR_1 | 2.02e-03 | 90 | 52 | 3 | PF00515 | |
| Domain | TPR_1 | 2.02e-03 | 90 | 52 | 3 | IPR001440 | |
| Domain | ARM-type_fold | 2.47e-03 | 339 | 52 | 5 | IPR016024 | |
| Domain | - | 2.62e-03 | 207 | 52 | 4 | 1.25.40.10 | |
| Domain | Ion_trans_dom | 3.94e-03 | 114 | 52 | 3 | IPR005821 | |
| Domain | Ion_trans | 3.94e-03 | 114 | 52 | 3 | PF00520 | |
| Domain | TPR-like_helical_dom | 4.00e-03 | 233 | 52 | 4 | IPR011990 | |
| Domain | CYCLIN | 5.01e-03 | 38 | 52 | 2 | SM00385 | |
| Domain | - | 5.54e-03 | 40 | 52 | 2 | 1.10.472.10 | |
| Domain | TPR | 5.56e-03 | 129 | 52 | 3 | SM00028 | |
| Domain | TPR_repeat | 6.05e-03 | 133 | 52 | 3 | IPR019734 | |
| Domain | Cyclin-like | 6.38e-03 | 43 | 52 | 2 | IPR013763 | |
| Domain | Kinesin-like_fam | 6.38e-03 | 43 | 52 | 2 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 6.67e-03 | 44 | 52 | 2 | PS00411 | |
| Domain | - | 6.67e-03 | 44 | 52 | 2 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 6.67e-03 | 44 | 52 | 2 | IPR001752 | |
| Domain | Kinesin | 6.67e-03 | 44 | 52 | 2 | PF00225 | |
| Domain | KISc | 6.67e-03 | 44 | 52 | 2 | SM00129 | |
| Domain | KINESIN_MOTOR_2 | 6.67e-03 | 44 | 52 | 2 | PS50067 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 6.70e-03 | 138 | 52 | 3 | IPR001245 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 1.66e-07 | 5 | 37 | 3 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 3.31e-07 | 6 | 37 | 3 | M47960 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.38e-06 | 9 | 37 | 3 | M47852 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.97e-06 | 10 | 37 | 3 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.71e-06 | 11 | 37 | 3 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 2.71e-06 | 11 | 37 | 3 | M27466 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.68e-06 | 13 | 37 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 4.68e-06 | 13 | 37 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 4.68e-06 | 13 | 37 | 3 | M47656 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 4.68e-06 | 13 | 37 | 3 | MM14553 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 8.83e-06 | 189 | 37 | 6 | MM15356 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 9.10e-06 | 16 | 37 | 3 | M26945 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 1.33e-05 | 203 | 37 | 6 | M27654 | |
| Pathway | REACTOME_KINESINS | 1.44e-05 | 57 | 37 | 4 | MM15714 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 1.57e-05 | 19 | 37 | 3 | M27423 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.57e-05 | 19 | 37 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.57e-05 | 19 | 37 | 3 | M47733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 1.84e-05 | 20 | 37 | 3 | M47688 | |
| Pathway | REACTOME_KINESINS | 1.88e-05 | 61 | 37 | 4 | M977 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.14e-05 | 21 | 37 | 3 | M47689 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 2.20e-05 | 131 | 37 | 5 | MM15497 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 2.46e-05 | 134 | 37 | 5 | M27751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.48e-05 | 22 | 37 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.48e-05 | 22 | 37 | 3 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.84e-05 | 23 | 37 | 3 | M47676 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 3.68e-05 | 25 | 37 | 3 | MM14511 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 4.66e-05 | 27 | 37 | 3 | M12123 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 4.66e-05 | 27 | 37 | 3 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 5.21e-05 | 28 | 37 | 3 | M924 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 7.83e-05 | 32 | 37 | 3 | MM14983 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 1.12e-04 | 36 | 37 | 3 | M1315 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 1.12e-04 | 36 | 37 | 3 | M39831 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.22e-04 | 98 | 37 | 4 | MM15352 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.32e-04 | 100 | 37 | 4 | M27650 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.66e-04 | 41 | 37 | 3 | M512 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.77e-04 | 108 | 37 | 4 | M17034 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.78e-04 | 42 | 37 | 3 | M791 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | 1.86e-04 | 630 | 37 | 8 | M11480 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 2.05e-04 | 44 | 37 | 3 | M39845 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 2.11e-04 | 113 | 37 | 4 | M16817 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 2.18e-04 | 645 | 37 | 8 | MM15232 | |
| Pathway | SIG_CHEMOTAXIS | 2.19e-04 | 45 | 37 | 3 | M5193 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 2.33e-04 | 116 | 37 | 4 | MM14855 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.33e-04 | 116 | 37 | 4 | MM15715 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 2.34e-04 | 46 | 37 | 3 | M8626 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.39e-04 | 9 | 37 | 2 | M47699 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 3.00e-04 | 50 | 37 | 3 | M47951 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 3.20e-04 | 126 | 37 | 4 | M705 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 3.56e-04 | 53 | 37 | 3 | MM15716 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_KTN1 | 3.63e-04 | 11 | 37 | 2 | M27490 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_KTN1 | 3.63e-04 | 11 | 37 | 2 | MM15218 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.76e-04 | 54 | 37 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.76e-04 | 54 | 37 | 3 | MM15202 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.76e-04 | 54 | 37 | 3 | M26911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 3.98e-04 | 55 | 37 | 3 | M47952 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | 4.55e-04 | 719 | 37 | 8 | MM14540 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 4.81e-04 | 725 | 37 | 8 | M27507 | |
| Pathway | KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.13e-04 | 13 | 37 | 2 | M47763 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 5.39e-04 | 61 | 37 | 3 | MM15071 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 5.62e-04 | 261 | 37 | 5 | M42565 | |
| Pathway | REACTOME_CA2_PATHWAY | 5.66e-04 | 62 | 37 | 3 | M27321 | |
| Pathway | REACTOME_HEMOSTASIS | 6.15e-04 | 571 | 37 | 7 | MM14472 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 8.07e-04 | 70 | 37 | 3 | M3115 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 8.07e-04 | 70 | 37 | 3 | M8232 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 8.76e-04 | 72 | 37 | 3 | MM14631 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 9.49e-04 | 74 | 37 | 3 | M48080 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 9.49e-04 | 74 | 37 | 3 | MM15962 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 9.88e-04 | 170 | 37 | 4 | M941 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.03e-03 | 76 | 37 | 3 | MM15051 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 1.03e-03 | 76 | 37 | 3 | M9052 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.11e-03 | 78 | 37 | 3 | M1921 | |
| Pathway | WP_KCNQ2RELATED_EPILEPSIES | 1.11e-03 | 19 | 37 | 2 | M48320 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | 1.15e-03 | 828 | 37 | 8 | M1058 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 1.28e-03 | 82 | 37 | 3 | M27110 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 1.47e-03 | 86 | 37 | 3 | M27206 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.47e-03 | 86 | 37 | 3 | M916 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.47e-03 | 86 | 37 | 3 | M601 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 1.52e-03 | 326 | 37 | 5 | M39379 | |
| Pathway | KEGG_GAP_JUNCTION | 1.67e-03 | 90 | 37 | 3 | M4013 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.67e-03 | 90 | 37 | 3 | M6467 | |
| Pathway | REACTOME_HEMOSTASIS | 1.70e-03 | 679 | 37 | 7 | M8395 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.78e-03 | 24 | 37 | 2 | M47671 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.94e-03 | 25 | 37 | 2 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.94e-03 | 25 | 37 | 2 | M47710 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 1.95e-03 | 95 | 37 | 3 | M29842 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.09e-03 | 26 | 37 | 2 | M47672 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.26e-03 | 27 | 37 | 2 | M47755 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 2.26e-03 | 100 | 37 | 3 | M27467 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 2.32e-03 | 101 | 37 | 3 | M1979 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.46e-03 | 103 | 37 | 3 | MM15196 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.67e-03 | 106 | 37 | 3 | M27077 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 3.36e-03 | 115 | 37 | 3 | M9387 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 3.78e-03 | 35 | 37 | 2 | M47774 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 4.74e-03 | 130 | 37 | 3 | M27454 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 4.84e-03 | 131 | 37 | 3 | MM15717 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 5.15e-03 | 134 | 37 | 3 | M29840 | |
| Pathway | WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY | 5.15e-03 | 41 | 37 | 2 | M39698 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 5.66e-03 | 43 | 37 | 2 | M47669 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 5.82e-03 | 140 | 37 | 3 | M27484 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 6.17e-03 | 143 | 37 | 3 | M27107 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 31979185 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 10874040 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 9808793 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 3.34e-09 | 3 | 53 | 3 | 24904548 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 20395455 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 17327232 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 17437169 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 16014380 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 18194433 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 17890015 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 18547250 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 36350267 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 3.34e-09 | 3 | 53 | 3 | 27777977 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 11413485 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 3.34e-09 | 3 | 53 | 3 | 23983250 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 3.34e-09 | 3 | 53 | 3 | 9858485 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 26009177 | ||
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 3.34e-09 | 3 | 53 | 3 | 17581770 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 20427533 | ||
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 3.34e-09 | 3 | 53 | 3 | 18241669 | |
| Pubmed | Receptor-activated single channels in intact human platelets. | 3.34e-09 | 3 | 53 | 3 | 1693919 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 19068129 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 23955339 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 25215520 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 1.34e-08 | 4 | 53 | 3 | 21424589 | |
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 28419336 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 11163362 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 1.34e-08 | 4 | 53 | 3 | 35494252 | |
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 28615414 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 10828023 | ||
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 3.33e-08 | 5 | 53 | 3 | 21568942 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ANK3 SND1 NEK5 NEK8 TTC21A CCDC150 ANKRD28 EEA1 KLC4 TRIP11 FBXO30 KLC3 DCTN3 | 6.59e-08 | 1321 | 53 | 13 | 27173435 |
| Pubmed | 6.66e-08 | 6 | 53 | 3 | 23463619 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 6.66e-08 | 6 | 53 | 3 | 21762810 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 6.66e-08 | 6 | 53 | 3 | 16844763 | |
| Pubmed | 6.66e-08 | 6 | 53 | 3 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 6.66e-08 | 6 | 53 | 3 | 25966694 | |
| Pubmed | 1.16e-07 | 7 | 53 | 3 | 11860456 | ||
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 1.16e-07 | 7 | 53 | 3 | 22495310 | |
| Pubmed | 2.79e-07 | 9 | 53 | 3 | 25737585 | ||
| Pubmed | Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development. | 5.47e-07 | 11 | 53 | 3 | 27514653 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MLXIPL HIVEP1 KIF26B OSBPL10 EDC4 KLC4 TRIP11 LYST KLC3 KIF11 | 6.11e-07 | 861 | 53 | 10 | 36931259 |
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 34630045 | ||
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 1.50e-06 | 15 | 53 | 3 | 28578927 | |
| Pubmed | Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. | 2.28e-06 | 2 | 53 | 2 | 9065779 | |
| Pubmed | Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve. | 2.28e-06 | 2 | 53 | 2 | 17496801 | |
| Pubmed | IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. | 2.28e-06 | 2 | 53 | 2 | 16195467 | |
| Pubmed | Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. | 2.28e-06 | 2 | 53 | 2 | 8663526 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 15890645 | ||
| Pubmed | Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye. | 2.28e-06 | 2 | 53 | 2 | 24901844 | |
| Pubmed | Fbxo30 Regulates Mammopoiesis by Targeting the Bipolar Mitotic Kinesin Eg5. | 2.28e-06 | 2 | 53 | 2 | 27117404 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 15632133 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33854148 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20813840 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 15713744 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 7559486 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20843799 | ||
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 2.28e-06 | 2 | 53 | 2 | 19120126 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18708078 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 15201137 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19528657 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 8063813 | ||
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 2.28e-06 | 2 | 53 | 2 | 8081734 | |
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 2.28e-06 | 2 | 53 | 2 | 23582047 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 1374893 | ||
| Pubmed | Distinct roles of inositol 1,4,5-trisphosphate receptor types 1 and 3 in Ca2+ signaling. | 2.28e-06 | 2 | 53 | 2 | 14707143 | |
| Pubmed | 5.04e-06 | 22 | 53 | 3 | 11696558 | ||
| Pubmed | 6.61e-06 | 24 | 53 | 3 | 10843712 | ||
| Pubmed | Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland. | 6.83e-06 | 3 | 53 | 2 | 21435446 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 12421829 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22992961 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 23223241 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 12032348 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 18250332 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 32320395 | ||
| Pubmed | MLXIPL SLK ANK3 SND1 SYNE1 TTC21A OSBPL10 ZNFX1 EDC4 TRIP11 ITPR2 | 8.54e-06 | 1431 | 53 | 11 | 37142655 | |
| Pubmed | 1.19e-05 | 29 | 53 | 3 | 32123907 | ||
| Pubmed | Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteins. | 1.36e-05 | 4 | 53 | 2 | 14685260 | |
| Pubmed | Abnormal taste perception in mice lacking the type 3 inositol 1,4,5-trisphosphate receptor. | 1.36e-05 | 4 | 53 | 2 | 17925404 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 18414036 | ||
| Pubmed | Ins(1,4,5)P3 receptor-mediated Ca2+ signaling and autophagy induction are interrelated. | 1.36e-05 | 4 | 53 | 2 | 22082873 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 21818117 | ||
| Pubmed | IRE1α/XBP1-mediated branch of the unfolded protein response regulates osteoclastogenesis. | 1.36e-05 | 4 | 53 | 2 | 26193638 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 19120137 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 27919044 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 11524429 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 23884412 | ||
| Pubmed | 1.37e-05 | 963 | 53 | 9 | 28671696 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 11782428 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 19706527 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 8081710 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 21436055 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 15613488 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.71e-05 | 38 | 53 | 3 | 30786075 | |
| Pubmed | Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells. | 3.40e-05 | 6 | 53 | 2 | 17416589 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.47e-05 | 256 | 53 | 5 | 33397691 | |
| Pubmed | The inhibitors of apoptosis (IAPs) and their emerging role in cancer. | 4.76e-05 | 7 | 53 | 2 | 9916987 | |
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 9990849 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 5.04e-05 | 1425 | 53 | 10 | 30948266 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 5.50e-05 | 440 | 53 | 6 | 34244565 | |
| Interaction | IRAG1 interactions | 5.45e-06 | 14 | 51 | 3 | int:IRAG1 | |
| Interaction | TESPA1 interactions | 8.35e-06 | 16 | 51 | 3 | int:TESPA1 | |
| Interaction | TRPC4 interactions | 2.61e-05 | 23 | 51 | 3 | int:TRPC4 | |
| Interaction | RASEF interactions | 3.38e-05 | 25 | 51 | 3 | int:RASEF | |
| Interaction | BBOX1 interactions | 5.33e-05 | 29 | 51 | 3 | int:BBOX1 | |
| Interaction | TRPC1 interactions | 5.33e-05 | 29 | 51 | 3 | int:TRPC1 | |
| Interaction | SGF29 interactions | 5.83e-05 | 164 | 51 | 5 | int:SGF29 | |
| Interaction | TRPC2 interactions | 6.25e-05 | 5 | 51 | 2 | int:TRPC2 | |
| Interaction | INSYN1 interactions | 6.72e-05 | 169 | 51 | 5 | int:INSYN1 | |
| Interaction | VCL interactions | 1.16e-04 | 305 | 51 | 6 | int:VCL | |
| Interaction | C2orf69 interactions | 1.31e-04 | 7 | 51 | 2 | int:C2orf69 | |
| Interaction | CHRNA3 interactions | 1.31e-04 | 39 | 51 | 3 | int:CHRNA3 | |
| Interaction | SSR1 interactions | 1.36e-04 | 453 | 51 | 7 | int:SSR1 | |
| Cytoband | 12p13 | 2.52e-03 | 64 | 53 | 2 | 12p13 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 8.57e-09 | 3 | 38 | 3 | 297 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 9.70e-05 | 115 | 38 | 4 | 769 | |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 1.19e-04 | 8 | 38 | 2 | 419 | |
| GeneFamily | NLR family | 1.25e-03 | 25 | 38 | 2 | 666 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 4.20e-03 | 46 | 38 | 2 | 622 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.44e-03 | 181 | 38 | 3 | 694 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 9.58e-08 | 188 | 53 | 6 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.12e-07 | 193 | 53 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-07 | 197 | 53 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.38e-07 | 200 | 53 | 6 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-06 | 169 | 53 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-06 | 169 | 53 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-06 | 171 | 53 | 5 | 4f2a83d8091f1fd29542d2e5add57fd482e921b5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-06 | 180 | 53 | 5 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 182 | 53 | 5 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 182 | 53 | 5 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-06 | 184 | 53 | 5 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-06 | 184 | 53 | 5 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.72e-06 | 185 | 53 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-06 | 189 | 53 | 5 | 057d7a03fdbe779122b203619a6f947f49b84d28 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 189 | 53 | 5 | 28c750ac56e3861fe7280e32839a4d8ce8bd8692 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-06 | 189 | 53 | 5 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-06 | 189 | 53 | 5 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-06 | 189 | 53 | 5 | 9f57a131902d23494bf389baf6e6e2d99f88b2c8 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 189 | 53 | 5 | efee01edd171bf569267b672fab05c421de6c92d | |
| ToppCell | PND10-Epithelial-Epithelial_Airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-06 | 189 | 53 | 5 | 407d8a59969d83f014600aae1a55092283a13970 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-06 | 189 | 53 | 5 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 3.02e-06 | 189 | 53 | 5 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-06 | 189 | 53 | 5 | e443b02502edaefa94567a9e8af5756e8e11ff30 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.10e-06 | 190 | 53 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.10e-06 | 190 | 53 | 5 | 5c012935ea5e35a2d0d08ea7dc04ffbe3c2a10ac | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.10e-06 | 190 | 53 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-06 | 191 | 53 | 5 | acd844b477a069b2dcf07b2998e1b5c87dc0eb94 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-06 | 191 | 53 | 5 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-06 | 191 | 53 | 5 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | Ciliated-cil-3|World / Class top | 3.26e-06 | 192 | 53 | 5 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.26e-06 | 192 | 53 | 5 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.26e-06 | 192 | 53 | 5 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.26e-06 | 192 | 53 | 5 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.35e-06 | 193 | 53 | 5 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.35e-06 | 193 | 53 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.43e-06 | 194 | 53 | 5 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.43e-06 | 194 | 53 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.43e-06 | 194 | 53 | 5 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.52e-06 | 195 | 53 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-06 | 195 | 53 | 5 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.52e-06 | 195 | 53 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-06 | 195 | 53 | 5 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-06 | 195 | 53 | 5 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.52e-06 | 195 | 53 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.61e-06 | 196 | 53 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-06 | 197 | 53 | 5 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.70e-06 | 197 | 53 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-06 | 197 | 53 | 5 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.70e-06 | 197 | 53 | 5 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-06 | 197 | 53 | 5 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-06 | 197 | 53 | 5 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.70e-06 | 197 | 53 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.70e-06 | 197 | 53 | 5 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-06 | 200 | 53 | 5 | cc906ff02fd335ff633b3b97afceb670494f910a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-06 | 200 | 53 | 5 | 79e59ab31d3d3385b1b072dc75508af9546c2e1b | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.98e-06 | 200 | 53 | 5 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-06 | 200 | 53 | 5 | 873def69bf55ccbfc944bc10c5afc06be019c312 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-06 | 200 | 53 | 5 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.98e-06 | 200 | 53 | 5 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.98e-06 | 200 | 53 | 5 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-06 | 200 | 53 | 5 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 128 | 53 | 4 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.06e-05 | 150 | 53 | 4 | 6c39e73a0b05d4b26589f333ce13924e3d373b8d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.10e-05 | 171 | 53 | 4 | 4fd2c7977c512c51507f055fc74b111c0228ed8b | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 173 | 53 | 4 | a40a52d8041d45dc3bef74fe55945ae07aa018d6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 173 | 53 | 4 | a7cc63bb3ab41feb9e4072700d44dbbbc62c47c6 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 173 | 53 | 4 | f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 173 | 53 | 4 | e3e3a67a5a93ef4475224a256d45ae24526383cc | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 173 | 53 | 4 | f3f67531f72d6d52e19c7f1f2db1ab4026fb70da | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.46e-05 | 174 | 53 | 4 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.46e-05 | 174 | 53 | 4 | 179a52d77899a929396b98d4ab2c270dd2ec708e | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.46e-05 | 174 | 53 | 4 | 9165a1094d345328e58962f4b2a20334c3e93ead | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.58e-05 | 175 | 53 | 4 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.96e-05 | 178 | 53 | 4 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 6.09e-05 | 179 | 53 | 4 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 6.09e-05 | 179 | 53 | 4 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.09e-05 | 179 | 53 | 4 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 6.23e-05 | 180 | 53 | 4 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.23e-05 | 180 | 53 | 4 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.36e-05 | 181 | 53 | 4 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.36e-05 | 181 | 53 | 4 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.50e-05 | 182 | 53 | 4 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.50e-05 | 182 | 53 | 4 | 3fddadb2ff75013ec6eeb415872667a6bae1da2d | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.50e-05 | 182 | 53 | 4 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.92e-05 | 185 | 53 | 4 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.92e-05 | 185 | 53 | 4 | 87151ab95530e70d61328b336518df58db584acb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-05 | 185 | 53 | 4 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.92e-05 | 185 | 53 | 4 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-05 | 185 | 53 | 4 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.07e-05 | 186 | 53 | 4 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.07e-05 | 186 | 53 | 4 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 186 | 53 | 4 | 02fbb02c495e7d64c4ab50e42e5197782f2c0816 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-05 | 186 | 53 | 4 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.22e-05 | 187 | 53 | 4 | 1399c703505211c510b3f14c7a2aa9930566c473 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.22e-05 | 187 | 53 | 4 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 7.37e-05 | 188 | 53 | 4 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.37e-05 | 188 | 53 | 4 | 5ba5cbb403518026e9040379fb5d99339ea977d8 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.52e-05 | 189 | 53 | 4 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.52e-05 | 189 | 53 | 4 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.52e-05 | 189 | 53 | 4 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| Drug | adenophostin A | 5.12e-06 | 2 | 52 | 2 | ctd:C085029 | |
| Drug | Isocaffeine | 5.12e-06 | 2 | 52 | 2 | CID000001326 | |
| Drug | adenophostin B | 5.12e-06 | 2 | 52 | 2 | CID000656722 | |
| Drug | benzene 1,2,4-trisphosphate | 5.12e-06 | 2 | 52 | 2 | CID000192376 | |
| Drug | 5-deoxy-5-fluoro-myo-inositol | 1.53e-05 | 3 | 52 | 2 | CID000195110 | |
| Drug | CHEBI:697555 | 3.06e-05 | 4 | 52 | 2 | CID009578246 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.19e-06 | 12 | 53 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | Anoxic Encephalopathy | 3.17e-06 | 2 | 53 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 3.17e-06 | 2 | 53 | 2 | C1527348 | |
| Disease | Anoxia of brain | 3.17e-06 | 2 | 53 | 2 | C0995195 | |
| Disease | Hypoxic Brain Damage | 3.17e-06 | 2 | 53 | 2 | C1140716 | |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 6.61e-05 | 7 | 53 | 2 | DOID:0080348 (implicated_via_orthology) | |
| Disease | Spastic Paraplegia | 1.13e-04 | 9 | 53 | 2 | C0037772 | |
| Disease | coffee consumption measurement | 3.24e-04 | 182 | 53 | 4 | EFO_0006781 | |
| Disease | birth weight, parental genotype effect measurement | 3.97e-04 | 192 | 53 | 4 | EFO_0004344, EFO_0005939 | |
| Disease | age at onset, smoking initiation | 5.31e-04 | 19 | 53 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | diet measurement | 5.32e-04 | 1049 | 53 | 8 | EFO_0008111 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 6.84e-04 | 222 | 53 | 4 | EFO_0008317, EFO_0020943 | |
| Disease | periodontitis | 6.96e-04 | 223 | 53 | 4 | EFO_0000649 | |
| Disease | birth weight | 7.42e-04 | 399 | 53 | 5 | EFO_0004344 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 9.00e-04 | 239 | 53 | 4 | EFO_0008317, EFO_0020945 | |
| Disease | Drug habituation | 1.17e-03 | 115 | 53 | 3 | C0013170 | |
| Disease | Substance-Related Disorders | 1.17e-03 | 115 | 53 | 3 | C0236969 | |
| Disease | Drug abuse | 1.17e-03 | 115 | 53 | 3 | C0013146 | |
| Disease | Drug Use Disorders | 1.17e-03 | 115 | 53 | 3 | C0013222 | |
| Disease | Drug Dependence | 1.17e-03 | 115 | 53 | 3 | C1510472 | |
| Disease | Substance Dependence | 1.17e-03 | 115 | 53 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 1.17e-03 | 115 | 53 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.17e-03 | 115 | 53 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 1.17e-03 | 115 | 53 | 3 | C4316881 | |
| Disease | Substance abuse problem | 1.20e-03 | 116 | 53 | 3 | C0740858 | |
| Disease | bipolar disorder (is_implicated_in) | 1.25e-03 | 29 | 53 | 2 | DOID:3312 (is_implicated_in) | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.36e-03 | 121 | 53 | 3 | EFO_0008595, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.56e-03 | 127 | 53 | 3 | EFO_0008595, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VAKLIIQQCQQLHCL | 1251 | Q13075 | |
| DCIQLQLQLNLAHNA | 1976 | Q9NR09 | |
| VNNQQLLCVLSQLEG | 266 | Q8NHS2 | |
| ILQVFSNILQHCGLQ | 201 | Q9H1I8 | |
| VECLQLLLSHNAQVN | 836 | O15084 | |
| SQLAALLQLQHQLRC | 2111 | Q8IYW2 | |
| QQLESLQQEACKLHQ | 331 | Q9BSW2 | |
| NLQVSCLNAEQNQHL | 276 | Q9UF12 | |
| CQAQQAHILQLLQQG | 1261 | Q6P2E9 | |
| QLLCENHNRELQNFL | 1926 | Q14571 | |
| FLQLLCENHNRDLQN | 1876 | Q14573 | |
| CQEQIEAVLLNSLQQ | 246 | P30279 | |
| VAKQLNNLALLCQNQ | 336 | Q9NSK0 | |
| LQLLCENHNRDLQNF | 1981 | Q14643 | |
| ALLNVISNQECNIKH | 626 | Q2TV78 | |
| ILCNNLHELQENTIC | 681 | P52732 | |
| ICATHLNQLKQEAIQ | 186 | Q2KJY2 | |
| LELCAVHALNNVLQQ | 21 | Q8TAC2 | |
| GNNLQQLVLKICQAH | 206 | Q6P3R8 | |
| QDVNLHEAILLCPNN | 311 | Q9Y4A8 | |
| AAVAQTNQNQLHLCV | 631 | Q9ULK4 | |
| QAAQNECQVLKLLNH | 46 | Q86SG6 | |
| DVAKQLNNLALLCQN | 331 | Q6P597 | |
| FQLSQEIKQQIHQCL | 521 | Q96MN2 | |
| LQRLAQIHIQQQDQC | 126 | O75935 | |
| QATLHQKDLDCQQLQ | 336 | Q15075 | |
| CTQLQAHLLVIQNLD | 106 | D3W0D1 | |
| HILQQNCIALRDSIQ | 256 | Q8NCX0 | |
| NHIVFENNQQLLCLE | 896 | Q7Z7M9 | |
| VQQLHQNLHRLQILC | 241 | Q5VVM6 | |
| QNLHRLQILCNSAEN | 246 | Q5VVM6 | |
| DINICNQNGLNALHL | 66 | Q12955 | |
| LHSIQIANHICNLIQ | 706 | Q99698 | |
| IANHICNLIQKGNIV | 711 | Q99698 | |
| LLQEICNLLIQQASN | 361 | Q9NYC9 | |
| NICTQVIDQNQNLHG | 291 | Q8TB52 | |
| LCSQAKLQAQQELLQ | 371 | P07332 | |
| ELQAQVENNQCISLL | 341 | A7E2F4 | |
| ILGLQVQQAEHCSIQ | 371 | Q9GZR2 | |
| LQCEANVRELHQLQN | 1136 | Q9H2G2 | |
| QRQVHECLTQLELIN | 8046 | Q8NF91 | |
| VQIILESCHNQNILG | 261 | Q7KZF4 | |
| IQNTQCLLNVEHLSA | 821 | Q7KZF4 | |
| AQIQKVNICLQNLIH | 101 | Q5SSQ6 | |
| IEELNAAINLCQQQL | 721 | Q9NP71 | |
| ECLNLLQQSVHQAGQ | 291 | Q9BXB5 | |
| VILLNCAQHLSQRLQ | 91 | Q495N2 | |
| LQFCHQRLQIISQAL | 231 | Q8NHS4 | |
| QLCIIVQTHSLQALQ | 321 | Q5GH76 | |
| QHLVAALLAQLCQPQ | 1176 | Q9BWH6 | |
| LCEQHCAILLQTEQN | 941 | Q8NDW8 | |
| LGNQLQLNQHCLDTA | 96 | Q92994 | |
| IVQLCFNEQSQQLLA | 481 | Q9P2E3 | |
| QELAQVQHSIGQLCN | 1286 | Q15643 | |
| HQQQKLALQDFLELC | 31 | Q9H521 | |
| VQQLCDINLLNQIHA | 1506 | P15822 | |
| LQHDAQEVLQCILGN | 196 | O94782 |